Treatment of Gout (Pain in joints) with Unani medicines Majoon-e-Yahya Bin Khalid and Roghan-e-Naf-e-Warm-e-Niqras

Clinical study on validation of Unani Pharmacopoeial formulation Majoon e Yahya Bin Khalid and Roghan e Naf e Niqras in Niqras (Gout)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033660

Enrollment

110

Registered

2021-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M100- Idiopathic gout

Interventions

Intervention1: Majoon-e-Yahya Bin Khalid and Roghan-e-Naf-e-Warm-e-Niqras: 5gm orally twice daily to be taken with water and massage with 2ml oil locally twice daily for twelve weeks respectively Cont

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of either sex between the age groups of 18 years to 65 years. 2. Subjects fulfilling the 2015ACR/EULAR-criteria for diagnosis of gout(>=8)

Exclusion criteria

Exclusion criteria: 1. Acute Gouty arthritis 2. Subjects having any systemic illness requiring long term treatment 3. Pregnant and lactating women 4. Intolerant to therapy 5. Subjects who received any local injection in the previous 3 months

Design outcomes

Primary

Measure	Time frame
Improvement in sign and symptoms of Niqras (Gout)Timepoint: every 2 weeks for twelve weeks	—

Secondary

Measure	Time frame
Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com9213511298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026